5-Amino-1MQ goes after fat from an angle nothing else does. Instead of suppressing appetite the way the GLP-1 compounds do, it reaches inside fat cells and changes what they do with energy, prompting them to burn fuel instead of storing it. In preclinical studies it reduced fat mass while animals ate exactly the same amount of food, which makes it one of the most intriguing metabolic targets in current research.
What 5-Amino-1MQ is
5-Amino-1MQ is a small molecule that selectively blocks an enzyme called NNMT (nicotinamide N-methyltransferase). NNMT is highly active in fat tissue, and in obesity its activity climbs even higher, which is what first drew researchers to it as a target. 5-Amino-1MQ was designed to be membrane-permeable, meaning it can actually get inside fat cells and act on the enzyme there, a property earlier NNMT inhibitors lacked. That ability to reach its target inside living adipocytes is what made it the go-to compound for this line of research.
What the research shows
The defining work came from Neelakantan and colleagues, who identified 5-Amino-1MQ as a selective, membrane-permeable NNMT inhibitor and tested it in diet-induced obese mice. The results were notable. The compound reduced body fat mass without any change in food intake, shrank fat-cell size by more than 30%, lowered cholesterol, and improved glucose tolerance. Because the animals ate the same amount, the fat loss came from a genuine metabolic shift inside the cells rather than from eating less.
Two findings make the early data especially attractive. The compound preserved lean muscle mass while reducing fat, so the change was specific to fat rather than general weight loss. And it proved highly selective, acting on NNMT without disturbing related enzymes, with a clean tolerability profile in the animal studies even at high doses. Newer research is now exploring how NNMT inhibition affects muscle function and aging as well.
How it works
NNMT burns through two valuable cellular resources, SAM (S-adenosylmethionine) and the building blocks of NAD+, in the process of methylation. When NNMT is overactive in fat tissue, it drains those resources and the cells settle into an energy-storing, low-activity state. By blocking the enzyme, 5-Amino-1MQ preserves SAM and raises NAD+ inside the fat cell. Higher NAD+ wakes up the sirtuin enzymes that drive mitochondrial activity and fat burning, so the adipocytes stop sitting idle and start oxidizing fuel. It is a different lever entirely from appetite suppression, which is exactly why it has drawn so much interest.
Quick facts
| 5-Amino-1MQ | |
|---|---|
| Type | Small-molecule NNMT inhibitor (membrane-permeable) |
| Target | NNMT, an enzyme highly active in fat tissue |
| Best known for | Reducing fat mass without changing food intake |
| Mechanism | Preserves SAM and raises NAD+, shifting fat cells to burn fuel |
| Preclinical results | Reduced fat mass, smaller fat cells, preserved lean mass |
| Research stage | Preclinical (animal and in vitro studies) |
| Form | Supplied as research-grade material |
What to look for when buying
For an emerging research compound, the integrity of the material is what makes the data meaningful. Look for a Certificate of Analysis (COA) from third-party testing and an HPLC-MS purity figure of 99% or higher. Every batch of Marek Pharma’s 5-Amino-1MQ is tested with a COA and ships from within Canada.
References
- Neelakantan H, et al. Selective and membrane-permeable small-molecule inhibitors of nicotinamide N-methyltransferase (NNMT) reduce fat mass in diet-induced obese mice. (NNMT inhibition and adipose metabolism research, 2017.)
- Subsequent NNMT-inhibition research on adipocyte metabolism, NAD+ salvage, and muscle function.
For laboratory and research use only.